This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Screening for Primary Hepatocellular Carcinoma Among Persons Infected With Hepatitis B Virus

William L. Heyward, MD; Anne P. Lanier, MD, MPH; Brian J. McMahon, MD; Mary Anne Fitzgerald, MPH; Steven Kilkenny, MD; Thaddeus R. Paprocki, MD

JAMA. 1985;254(21):3052-3054.

Abstract
High rates of hepatitis B virus infection and primary hepatocellular carcinoma are present among Alaskan Natives. To determine if primary hepatocellular carcinoma could be detected at an early surgically resectable stage, serological screening for elevated -fetoprotein levels was done semiannually among Alaskan Natives infected with hepatitis B virus. During a 26-month screening period, 3,387 -fetoprotein tests were performed on 1,394 persons. Of 126 persons with elevated levels of -fetoprotein (>25 ng/mL), nine males were found to have primary hepatocellular carcinoma (all with -fetoprotein levels >350 ng/mL). Six of these nine persons were asymptomatic for primary hepatocellular carcinoma and four had small tumors (<6 cm) that were surgically resected. After surgery, the -fetoprotein levels in all four patients fell to normal and have remained normal after a follow-up of four to 20 months (median, ten months). -Fetoprotein screening proved to be an effective approach in this population in detecting primary hepatocellular carcinoma at a potentially curable stage and should be considered in other individuals or populations infected with hepatitis B virus.

(JAMA 1985;254:3052-3054)

Author Affiliations
From the Arctic Investigations Laboratory, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, US Department of Health and Human Services (Drs Heyward and Lanier and Ms Fitzgerald); and the Alaska Native Medical Center, Alaska Area Native Health Service, Indian Health Service (Drs McMahon, Kilkenny, and Paprocki), Anchorage, Alaska.

Footnotes
Reprint requests to Centers for Disease Control, 225 Eagle St, Anchorage, AK 99501 (Dr Heyward).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B
Haber et al.
Pediatrics 2009;124:e1007-e1013.
ABSTRACT | FULL TEXT  

Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
Kanwal et al.
ANN INTERN MED 2005;142:821-831.
ABSTRACT | FULL TEXT  

Hepatocellular Carcinoma and Hepatitis Virus
Birrer et al.
Annals of Clinical & Laboratory Science 2003;33:39-54.
ABSTRACT | FULL TEXT  

Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
McMahon et al.
ANN INTERN MED 2001;135:759-768.
ABSTRACT | FULL TEXT  

Clinical Applications of Serum Tumor Markers
Bates
ANN INTERN MED 1991;115:623-638.
ABSTRACT  

Primary Hepatocellular Carcinoma after Orthotopic Liver Transplantation for Chronic Hepatitis B Infection
Luketic et al.
ANN INTERN MED 1991;114:212-213.
ABSTRACT  

International Adoptees and Hepatitis B Virus Infection
MURRAY
Arch Pediatr Adolesc Med 1990;144:523-523.
ABSTRACT  

Screening for Hepatocellular Carcinoma in High-Risk Individuals: A Clinical Review
Regan
Arch Intern Med 1989;149:1741-1744.
ABSTRACT  

Cost-effectiveness of Prenatal Screening and Immunization for Hepatitis B Virus
Arevalo and Washington
JAMA 1988;259:365-369.
ABSTRACT  

Hepatocarcinoma in a Child With the Alagille Syndrome
Kaufman et al.
Arch Pediatr Adolesc Med 1987;141:698-700.
ABSTRACT